Before joining Euclid Law as a Senior Consultant, Gavin Robert was a partner in Linklaters Competition/Antitrust Department for 14 years. Gavin retired as a partner in 2013 to become a Panel Member at the UK Competition & Markets Authority (and previously the UK Competition Commission), where he decided complex merger, market and antitrust cases for five years until March 2018. Gavin has expertise across the full breadth of EU and UK competition law, including mergers, joint ventures, cartels, agreements, information exchange, abuse of a dominant position and State aid. He also has experience of a wide range of sectors, including in particular healthcare, natural resources and financial services. Gavin also teaches competition law as part of the Masters programme at Cambridge University. Since 2013 until joining Euclid, Gavin was a part-time consultant with Linklaters. In addition to EU and UK competition law, Gavin has considerable experience of other jurisdictions around the world, especially China and Hong Kong where he led the development of Linklaters’ competition practice for a number of years. Gavin was listed in GCR’s 40 under 40 Competition Lawyers, and has been consistently ranked in Tier 1 for Competition in most leading directories, including Chambers and Legal 500. Gavin obtained an LLM and MA from Cambridge University, and a Licence Speciale en Droit from the Institut d’Etudes Europeenes at the Free University of Brussels.
629
On 5 January 2012, the PRC Ministry of Commerce (“MOFCOM”) published on its website the long-awaited Interim Measures on Investigation into and Handling of Concentrations of Business Operators that have not been Notified in Accordance with Laws (the “Measures”). The Measures set out details of (...)
258
On 31 October 2011, the Ministry of Commerce of the People’s Republic of China (“MOFCOM”) announced its eighth conditional clearance decision, approving the acquisition of Savio by Penelope subject to an equity divestiture. This is the third decision since the introduction of the AML to (...)
168
On 25 October 2011, the Bills Committee considering the proposed Hong Kong Competition Bill (the “Bill”) discussed the Hong Kong Government’s proposed amendments to the Bill. The amendments seek to address some of the concerns that have been raised by the business community in Hong Kong. (...)
384
On 2 September 2011, the PRC Ministry of Commerce (the “MOFCOM”) published on its website the Interim Provisions on Assessment of Competitive Impact of Concentrations of Business Operators (the “Interim Provisions”), which came into effect on 5 September 2011. The Interim Provisions elaborate (...)
258
On 2 June 2011, under two months into Phase 2, the Ministry of Commerce of the People’s Republic of China (“MOFCOM”) publicly announced its decision approving the merger of Uralkali with Silvinit, leading to the creation of the world’s second largest potassium chloride supplier, subject to (...)
124
On 25 April 2011, the Supreme People’s Court of China (the “SPC”) published on its website a draft of the long-awaited Provisions by the Supreme People’s Court on the Issues Regarding the Application of Law in Handling Anti-monopoly Civil Litigation Cases (the “Provisions”) for public (...)
337
The State Administration for Industry and Commerce (“SAIC”) recently published on its website details of a case brought by the Administration for Industry & Commerce (“AIC”) of Jiangsu Province against a local construction materials and machinery association and its respective members for (...)
152
On 7 January 2011, the State Administration for Industry and Commerce (“SAIC”) published three substantive Regulations on enforcement of the Anti- Monopoly Law (“AML”), regarding Monopolistic Agreements, Abuse of Dominance and Abuse of Administrative Powers. In May 2009 and May 2010, SAIC (...)
195
In a statement on 4 January 2011, the PRC National Development and Reform Commission (the ”NDRC”), the department in charge of price administration, announced that it has fined the Paper Manufacture Industry Association in Fuyang City, Zhejiang Province RMB 500,000 for organising a cartel. (...)
221
The European Commission has revised its rules for the assessment of co- operation agreements between competitors, so called horizontal co-operation agreements. The new rules consist of two updated Block Exemption Regulations covering R&D and specialisation / joint production agreements and (...)
342
On 13 August 2010, the Ministry of Commerce of the People’s Republic of China (“MOFCOM”) issued a conditional approval for the proposed acquisition of Alcon (“Alcon”) by Novartis AG (“Novartis”). The decision was issued after a merger review of just under four months (one month for Phase One (...)
1083
On 6 October, the European Court of Justice (‘ECJ’) issued another “score draw” judgment in the long-running battle of R&D-based pharmaceutical companies to limit parallel trade in medicines across the EU. While the ECJ required the European Commission to conduct an in-depth examination of (...)
271
The European Commission presented its Preliminary Report into the pharmaceutical sector (which runs to 426 pages) at a public hearing on 28 November. The deadline for comments on the Report is 31 January 2009. Click here for a copy of the Report, the Commission’s press release and the (...)
276
In a judgment handed down on 29 September, the Competition Appeal Tribunal (CAT), dismissed an appeal brought by British Sky Broadcasting Group plc (Sky) against a decision of the Competition Commission (CC). The CAT upheld part of an appeal against the same decision brought by Virgin Media (...)
319
On 11 December 2007, the OFT issued the results of its market study into the distribution of medicines in the UK. The review was initiated after Pfizer announced it would be introducing a Direct to Pharmacy (DTP) distribution model, appointing Unichem as its exclusive Logistics Service (...)
208
On Wednesday, the European Commission issued new Guidelines on the method of setting fines on companies infringing competition law - replacing the old 1998 Guidelines. The stated aims of the new Guidelines are to bring greater transparency and predictability to fining practice and to increase (...)
